Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00550303 | Study Comparing Formulations of Bazedoxifene/Conjugated Estrogens | PHASE1 | COMPLETED | 28 | — | — | Oct 1, 2007 | Nov 1, 2007 | Dec 27, 2007 | - | — |
| NCT00465075 | Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations in Fed and Fasting in Healthy, Postmenopausal Women | PHASE1 | COMPLETED | 24 | — | — | Mar 1, 2007 | Apr 1, 2007 | Dec 28, 2007 | 1 | United States |
| Name | Type | Description |
|---|---|---|
| bazedoxifene/conjugated estrogens combination | DRUG | - |
Inclusion Criteria: * Healthy, post menopausal women ages 45 to 70 Exclusion Criteria: * Male subjects